The fragmentation reactions of anti-platelet drugs: Clopidogrel and ticlopidine

Journal of Mass Spectrometry

Volumn 42, Issue 3, 2007, Pages 405-406

  Danikiewicz, Witold ^a   Świst, Małgorzata ^a  

^a INSTITUTE OF ORGANIC CHEMISTRY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; TICLOPIDINE;

ACCURACY; ATOM; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG PURITY; DRUG STRUCTURE; FRAGMENTATION REACTION; HUMAN; LETTER; MASS SPECTROMETRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; PLATELET AGGREGATION INHIBITORS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; THERAPEUTIC EQUIVALENCY; TICLOPIDINE;

EID: 33947237344     PISSN: 10765174     EISSN: 10969888     Source Type: Journal    
DOI: 10.1002/jms.1145     Document Type: Letter

References (6)

1. Liu ZC, Uetrecht JP. Metabolism of ticlopidine by activated neutrophils: implication for ticlopidine-induced agranulocytosis. Drug Metab. Dispos. 2000; 28: 726.
2. Mitakos A, Panderi I. A validated LC method for the determination of clopidogrel in pharmaceutical preparations. J. Pharm. Biomed. Anal. 2002; 28: 431.
3. Gomez Y, Adams E, Hogmartens J. Analysis of purity in 19 drug product tablets containing clopidogrel: 18 copies versus the original brand. J. Pharm. Biomed. Anal. 2004; 34: 341.
4. Borges NC, Mendes GD, Borges A, de Oliveira SE, Barrientos-Astigarraga RE, De Nucci G. Ticlopidine quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry. Application to bioequivalence study. J. Mass Spectrom. 2004; 39: 1562.
5. Yoneda K, Iwamura R, Kishi H, Mizukami Y, Mogami K, Kobayashi S. Identification of the active metabolite of ticlopidine from rat in vitro metabolites. Br. J. Pharmacol. 2004; 142: 551.
6. Porter QN. Mass Spectrometry of Heterocyclic Compounds. John Wiley: New York, 1985; 64.